SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Surgery Partners, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97’

On:  Monday, 2/26/24, at 4:45pm ET   ·   For:  12/31/23   ·   Accession #:  1638833-24-29   ·   File #:  1-37576

Previous ‘10-K’:  ‘10-K’ on 3/1/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   36 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/26/24  Surgery Partners, Inc.            10-K       12/31/23   99:11M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.10M 
 2: EX-21.1     Subsidiaries List                                   HTML    186K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     27K 
 7: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     45K 
                Awarded Compensation                                             
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     31K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
13: R1          Cover                                               HTML     93K 
14: R2          Audit Information                                   HTML     32K 
15: R3          Consolidated Balance Sheets                         HTML    147K 
16: R4          Consolidated Balance Sheets (Parenthetical)         HTML     47K 
17: R5          Consolidated Statements of Operations               HTML    144K 
18: R6          Consolidated Statements of Comprehensive Income     HTML     56K 
                (Loss)                                                           
19: R7          Consolidated Statements of Comprehensive Income     HTML     29K 
                (Loss) (Parenthetical)                                           
20: R8          Consolidated Statements of Stockholders' Equity     HTML     92K 
21: R9          Consolidated Statements of Cash Flows               HTML    133K 
22: R10         Organization and Summary of Accounting Policies     HTML    127K 
23: R11         Acquisitions, Disposals and Deconsolidations        HTML     44K 
24: R12         Property and Equipment                              HTML     45K 
25: R13         Goodwill and Intangible Assets                      HTML     70K 
26: R14         Long-Term Debt                                      HTML     67K 
27: R15         Leases                                              HTML    160K 
28: R16         Derivatives and Hedging Activities                  HTML    106K 
29: R17         Earnings Per Share                                  HTML     59K 
30: R18         Income Taxes                                        HTML    108K 
31: R19         Equity-Based Compensation                           HTML     77K 
32: R20         Employee Benefit Plans                              HTML     34K 
33: R21         Other Current Liabilities                           HTML     39K 
34: R22         Commitments and Contingencies                       HTML     41K 
35: R23         Segment Reporting                                   HTML     92K 
36: R24         Subsequent Events                                   HTML     30K 
37: R25         Pay vs Performance Disclosure                       HTML     39K 
38: R26         Insider Trading Arrangements                        HTML     33K 
39: R27         Organization and Summary of Accounting Policies     HTML    128K 
                (Policies)                                                       
40: R28         Organization and Summary of Accounting Policies     HTML     95K 
                (Tables)                                                         
41: R29         Property and Equipment (Tables)                     HTML     42K 
42: R30         Goodwill and Intangible Assets (Tables)             HTML     96K 
43: R31         Long-Term Debt (Tables)                             HTML     55K 
44: R32         Leases (Tables)                                     HTML    106K 
45: R33         Derivatives and Hedging Activities (Tables)         HTML    105K 
46: R34         Earnings Per Share (Tables)                         HTML     53K 
47: R35         Income Taxes (Tables)                               HTML    106K 
48: R36         Equity-Based Compensation (Tables)                  HTML     67K 
49: R37         Other Current Liabilities (Tables)                  HTML     39K 
50: R38         Segment Reporting (Tables)                          HTML     93K 
51: R39         Organization and Summary of Accounting Policies -   HTML     65K 
                Narrative (Details)                                              
52: R40         Organization and Summary of Accounting Policies -   HTML     42K 
                Revenues by Service Type (Details)                               
53: R41         Organization and Summary of Accounting Policies -   HTML     61K 
                Revenues by Sources (Details)                                    
54: R42         Organization and Summary of Accounting Policies -   HTML     37K 
                Non-Controlling Interests - Redeemable (Details)                 
55: R43         Organization and Summary of Accounting Policies -   HTML     33K 
                Medicare Accelerated Payments and Deferred                       
                Governmental Grants (Details)                                    
56: R44         Organization and Summary of Accounting Policies -   HTML     53K 
                Schedule of Carrying Amount and Fair Value of                    
                Long-Term Debt (Details)                                         
57: R45         Organization and Summary of Accounting Policies -   HTML     51K 
                Variable Interest Entities (Details)                             
58: R46         Acquisitions, Disposals and Deconsolidations -      HTML     74K 
                Acquisitions (Details)                                           
59: R47         Acquisitions, Disposals and Deconsolidations -      HTML     69K 
                Disposals and Deconsolidations (Details)                         
60: R48         Property and Equipment - Narrative (Details)        HTML     44K 
61: R49         Property and Equipment - Schedule of Property and   HTML     53K 
                Equipment (Details)                                              
62: R50         Goodwill and Intangible Assets - Narrative          HTML     48K 
                (Details)                                                        
63: R51         Goodwill and Intangible Assets - Changes in         HTML     35K 
                Carrying Amount of Goodwill (Details)                            
64: R52         Goodwill and Intangible Assets - Components of      HTML     47K 
                Intangible Assets (Details)                                      
65: R53         Goodwill and Intangible Assets - Future             HTML     43K 
                Amortization of Intangible Assets (Details)                      
66: R54         Long-Term Debt - Schedule of Long-Term Debt         HTML     68K 
                (Details)                                                        
67: R55         Long-Term Debt - New Credit Facilities (Details)    HTML     95K 
68: R56         Long-Term Debt - 6.750% Senior Unsecured Notes due  HTML     53K 
                2025 (Details)                                                   
69: R57         Long-Term Debt - 10.000% Senior Unsecured Notes     HTML     62K 
                due 2027 (Details)                                               
70: R58         Long-Term Debt - Maturities of Debt Obligations     HTML     47K 
                (Details)                                                        
71: R59         Leases - Narrative (Details)                        HTML     47K 
72: R60         Leases - Schedule of Components of Right-of-use     HTML     68K 
                Assets and Liabilities Related to Leases (Details)               
73: R61         Leases - Lease Expense and Cash Flow Information    HTML     56K 
                (Details)                                                        
74: R62         Leases - Maturities of Lease Liabilities (Details)  HTML     67K 
75: R63         Derivatives and Hedging Activities - Schedule of    HTML     61K 
                Interest Rate Swaps and Interest Rate Caps                       
                Outstanding (Details)                                            
76: R64         Derivatives and Hedging Activities - Narrative      HTML     65K 
                (Details)                                                        
77: R65         Derivatives and Hedging Activities - Schedule of    HTML     49K 
                Derivative Instruments in Statement of Financial                 
                Position, Fair Value (Details)                                   
78: R66         Derivatives and Hedging Activities - Pre-tax        HTML     50K 
                Effect of Derivatives on AOCI and Statement of                   
                Operations (Details)                                             
79: R67         Earnings Per Share - Reconciliation of Numerator    HTML     81K 
                and Denominator of Basic and Diluted Earnings per                
                Share (Details)                                                  
80: R68         Earnings Per Share - Narrative (Details)            HTML     59K 
81: R69         Income Taxes - Narrative (Details)                  HTML     54K 
82: R70         Income Taxes - Income Tax Expense (Benefit)         HTML     44K 
                (Details)                                                        
83: R71         Income Taxes - Income Tax Rate Reconciliation       HTML     56K 
                (Details)                                                        
84: R72         Income Taxes - Temporary Differences and            HTML     78K 
                Approximate Tax Effects of Deferred Tax Asset and                
                Liability (Details)                                              
85: R73         Income Taxes - Gross Unrecognized Tax Benefits      HTML     32K 
                (Details)                                                        
86: R74         Equity-Based Compensation - Narrative (Details)     HTML     96K 
87: R75         Equity-Based Compensation - Restricted and          HTML     52K 
                Performance Share-Based Activity (Details)                       
88: R76         Equity-Based Compensation - Summary of Options      HTML     57K 
                Activity (Details)                                               
89: R77         Employee Benefit Plans (Details)                    HTML     31K 
90: R78         Other Current Liabilities (Details)                 HTML     40K 
91: R79         Commitments and Contingencies (Details)             HTML     44K 
92: R80         Segment Reporting - Schedule of Segment Revenue     HTML     90K 
                and Operating Income (Details)                                   
93: R81         Segment Reporting - Assets and Cash Purchases of    HTML     48K 
                Property and Equipment by Operating Segment                      
                (Details)                                                        
94: R82         Subsequent Events (Details)                         HTML     40K 
96: XML         IDEA XML File -- Filing Summary                      XML    179K 
99: XML         XBRL Instance -- sgry-20231231_htm                   XML   2.55M 
95: EXCEL       IDEA Workbook of Financial Report Info              XLSX    199K 
 9: EX-101.CAL  XBRL Calculations -- sgry-20231231_cal               XML    302K 
10: EX-101.DEF  XBRL Definitions -- sgry-20231231_def                XML    811K 
11: EX-101.LAB  XBRL Labels -- sgry-20231231_lab                     XML   2.54M 
12: EX-101.PRE  XBRL Presentations -- sgry-20231231_pre              XML   1.49M 
 8: EX-101.SCH  XBRL Schema -- sgry-20231231                         XSD    219K 
97: JSON        XBRL Instance as JSON Data -- MetaLinks              671±  1.01M 
98: ZIP         XBRL Zipped Folder -- 0001638833-24-000029-xbrl      Zip    613K 


‘EX-97’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
Exhibit 97
SURGERY PARTNERS, INC.
EXECUTIVE COMPENSATION RECOVERY POLICY

In accordance with the Rule 5608 of the Nasdaq Stock Market and Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors of Surgery Partners, Inc., a Delaware corporation (the “Company”), has adopted this policy regarding the recovery of erroneously awarded Incentive-Based Compensation Received by Executive Officers under certain circumstances (this “Policy”).

I.    Defined Terms
    
    Unless the context otherwise requires, the following definitions apply for purposes of this Policy:

    1.1    Accounting Restatement means an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements (commonly referred to as a “Big R” restatement), or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (commonly referred to as a “little r” restatement).

    1.2    Award means an award of Incentive-Based Compensation, which generally is subject to vesting and/or performance conditions, or is granted based on satisfaction of performance conditions.

    1.3    Committee means the Compensation, Culture and People Committee of the Board of Directors or such other committee designated by the Board of Directors.
    
1.4    Executive Officer means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. For the avoidance of doubt, the identification of an executive officer for purposes of this Policy shall at least include each executive officer who is or was identified pursuant to Item 401(b) of Regulation S-K, as well as the principal accounting officer (or, if there is no principal accounting officer, the controller).

1.5    Financial Reporting Measures means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures. Stock price and total shareholder return (and any measures that are derived wholly or in part from stock price or total shareholder return) shall, for purposes of this Policy, be considered Financial Reporting Measures. For the avoidance of doubt, a Financial Reporting Measure need not be presented in the Company’s financial statements or included in a filing with the Securities and Exchange Commission.




1.6    Incentive-Based Compensation means any compensation that is granted, accrued or vested based wholly or in part upon the attainment of a Financial Reporting Measure of the Company.
 
1.7    Received means, with respect to any Incentive-Based Compensation, actual or deemed receipt, and Incentive-Based Compensation shall be deemed received in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation to the Executive Officer occurs after the end of that period.

1.8    Restatement Date means the earlier to occur of (i) the date the Board of Directors, the Committee or the officers of the Company authorized to take such action if action by the Board of Directors is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.

II.    Authority to Recover Incentive-Based Compensation

2.1    Accounting Restatement. In the event that the Company is required to prepare an Accounting Restatement, then the Company shall recover reasonably promptly the amount of erroneously awarded Incentive-Based Compensation Received by any Executive Officer in a manner consistent with the terms described in this Section 2.1.

(a)Amount to be Recovered. The amount of Incentive-based Compensation to be recovered shall be the amount Received that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received by an Executive Officer had it been determined based on the Accounting Restatement, and shall be computed without regard to any taxes paid. For Incentive-Based Compensation based on stock price or total shareholder return, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement:

i.The amount shall be based on the Committee’s reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was Received; and
ii.The Company shall maintain documentation of such reasonable estimate and provide the relevant documentation as required to the Nasdaq.

(b)Incentive-Based Compensation Performance Periods Subject to Recovery. The requirements of this Section 2.1 shall apply to all Incentive-Based Compensation Received by a person:

i.On or after October 2, 2023;
ii.After beginning service as an Executive Officer;
iii.Who served as an Executive Officer at any time during the applicable performance period relating to any Incentive-Based Compensation;
    2


iv.While the Company has a class of securities listed on a national securities exchange or a national securities association; and
v.During the three completed fiscal years immediately preceding the Restatement Date, as well as any stub period or transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years (except that a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of at least nine months shall count as a completed fiscal year).
2.2    General Terms for Recovery
(a)Effect of Impracticability of Recovery. The Company is not required to recover erroneously awarded Incentive-Based Compensation to the extent that the Committee has made a determination that recovery would be impracticable and any of the following conditions are met:
i.The Committee determines that the direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered. Before making this determination, the Company shall make a reasonable attempt to recover the erroneously awarded Incentive-Based Compensation, document such attempt(s), and provide such documentation to the Nasdaq; or
ii.Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations thereunder.
(b)Method of Recovery. The Committee shall have the discretion to determine, based on the particular facts and circumstances, the appropriate means of recovery of Incentive-Based Compensation in accordance with this Policy including, but not limited to, (1) seeking reimbursement of all or part of an Award previously paid to the Executive Officer, (2) cancelling prior Awards, whether vested or unvested or paid or unpaid, (3) cancelling or setting-off against planned future Awards, and (4) any other method authorized by applicable law or contract that the Committee deems reasonable. To the extent that an Executive Officer fails to repay to the Company when due all Incentive-Based Compensation subject to recovery under this Policy, the Company shall take all actions reasonable and appropriate to recover such Incentive-Based Compensation from the applicable Executive Officer.
III.    Administration
    3.1    Authority of Committee. This Policy shall be administered by the Committee. Except as limited by law, or by the governing documents and policies of the Company, and subject to the provisions of this Policy, the Committee shall have full power, authority, and sole and exclusive discretion to construe, interpret and administer this Policy. In addition, the Committee shall have full and exclusive power to adopt such rules, regulations and guidelines for carrying out this Policy as it may
    3


deem necessary or proper, all of which power shall be executed in the best interests of the Company and in keeping with the objectives of this Policy.
    3.2    Decisions Binding. In making any determination or in taking or not taking any action under this Policy, the Committee may obtain and may rely on the advice of consultants, advisors and experts, including advisors otherwise engaged by the Company. Actions and decisions of the Committee under this Policy shall be in the Committee’s sole and absolute discretion and shall be conclusive and binding on all parties.
    3.3    Prohibition on Indemnification. The Company shall not indemnify any Executive Officer against the loss of Incentive-Based Compensation under this Policy.
    3.4    Acknowledgement. Each Executive Officer shall execute and deliver to the Company an acknowledgement and agreement with respect to this Policy in the form attached hereto as Exhibit A. Additionally, the Committee may require that any employment agreement, equity award agreement or similar agreement shall, as a condition to the grant of any benefit thereunder, require an Executive Officer to agree to abide by the terms of this Policy.
    3.5    Other Recoupment Rights. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.

    4


Exhibit A
Acknowledgement and Agreement with Respect to Executive Compensation Recovery Policy
By my signature below, I acknowledge and agree that:
(A)    I have received and read the attached Executive Compensation Recovery Policy (this “Policy”).
(B)    I hereby agree to abide by all of the terms of this Policy both during and after my employment with the Company, including, without limitation, by promptly repaying or returning any erroneously awarded Incentive-Based Compensation to the Company as determined in accordance with this Policy.
Signature:                     
Printed Name:                     
Date:                 

    5

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/26/248-K
For Period end:12/31/23
10/2/23
 List all Filings 


36 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/20/23  Surgery Partners, Inc.            8-K:1,2,9  12/19/23   11:2.3M                                   Toppan Merrill/FA
 8/01/23  Surgery Partners, Inc.            10-Q        6/30/23   66:89M
 3/01/23  Surgery Partners, Inc.            10-K       12/31/22  101:12M
12/22/22  Surgery Partners, Inc.            8-K:3,8,9  12/22/22   11:218K                                   Toppan Merrill/FA
11/08/22  Surgery Partners, Inc.            10-Q        9/30/22   65:9.7M
 5/03/22  Surgery Partners, Inc.            10-Q        3/31/22   70:6.9M
 3/01/22  Surgery Partners, Inc.            10-K       12/31/21  108:13M
 1/10/22  Surgery Partners, Inc.            8-K:2,5,9   1/05/22   13:520K
11/22/21  Surgery Partners, Inc.            8-K:1,2,9  11/19/21   11:315K                                   Toppan Merrill/FA
 8/04/21  Surgery Partners, Inc.            10-Q        6/30/21   71:7.6M
 5/05/21  Surgery Partners, Inc.            8-K:1,2,9   5/03/21   11:1.9M                                   Toppan Merrill/FA
 3/10/21  Surgery Partners, Inc.            10-K       12/31/20  103:13M
 8/05/20  Surgery Partners, Inc.            10-Q        6/30/20   71:8.2M
 7/31/20  Surgery Partners, Inc.            8-K:1,2,9   7/30/20    2:143K                                   Toppan Merrill/FA
 4/22/20  Surgery Partners, Inc.            8-K:1,2,9   4/16/20    3:1.7M
 1/13/20  Surgery Partners, Inc.            8-K:2,5,9   1/13/20    4:249K
 4/12/19  Surgery Partners, Inc.            8-K:1,2,9   4/11/19    2:1.4M                                   Toppan Merrill/FA
 3/25/19  Surgery Partners, Inc.            8-K:1,7,9   3/25/19    4:2.2M                                   Toppan Merrill/FA
 3/15/19  Surgery Partners, Inc.            10-K       12/31/18   99:15M
 2/12/19  Surgery Partners, Inc.            8-K:5,9     2/12/19    3:111K
12/20/18  Surgery Partners, Inc.            8-K:5,9    12/16/18    2:57K                                    Toppan Merrill/FA
 3/16/18  Surgery Partners, Inc.            10-K       12/31/17  115:17M
 1/08/18  Surgery Partners, Inc.            8-K:5,9     1/04/18    3:149K                                   Toppan Merrill/FA
11/03/17  Surgery Partners, Inc.            8-K:3,5,9  10/30/17    2:102K                                   Toppan Merrill/FA
 9/01/17  Surgery Partners, Inc.            8-K:1,2,3,5 8/31/17    9:2.3M                                   Toppan Merrill/FA
 7/06/17  Surgery Partners, Inc.            8-K:1,2,9   6/30/17    2:1.4M                                   Toppan Merrill/FA
 5/11/17  Surgery Partners, Inc.            8-K:1,3,5,9 5/09/17    6:1.3M                                   Donnelley … Solutions/FA
 5/10/17  Surgery Partners, Inc.            10-Q        3/31/17   67:6.5M
 4/03/17  Surgery Partners, Inc.            8-K:5,9     3/31/17    2:58K
11/10/16  Surgery Partners, Inc.            10-Q        9/30/16   74:8.1M
 7/05/16  Surgery Partners, Inc.            8-K:5,9     7/05/16    2:47K                                    Donnelley … Solutions/FA
 3/15/16  Surgery Partners, Inc.            8-K:5,9     3/09/16    2:33K                                    Donnelley … Solutions/FA
 3/11/16  Surgery Partners, Inc.            10-K       12/31/15  110:13M
11/13/15  Surgery Partners, Inc.            10-Q        9/30/15   86:9.9M
 9/21/15  Surgery Partners, Inc.            S-1/A                 12:5.2M                                   Donnelley … Solutions/FA
 9/14/15  Surgery Partners, Inc.            S-1/A9/11/15   14:5M                                     Donnelley … Solutions/FA
Top
Filing Submission 0001638833-24-000029   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 1:02:40.3am ET